Fengmei Zheng

Discovery of BIIB068: A Selective, Potent, Reversible Bruton’s Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases

Bin Ma, Tonika Bohnert, Kevin L. Otipoby et al. · Journal of Medicinal Chemistry · 2020 · 36 citations · Full text

Mode of Attack of Atomic Carbon on Benzene Rings

B.M. Armstrong, Fengmei Zheng, Philip B. Shevlin · Journal of the American Chemical Society · 1998 · 31 citations

Initial Insertion, Fluoroboric Acid, Engineering +10

Haploidentical‐ versus identical‐sibling transplant for high‐risk pediatric AML: A multi‐center study

Fengmei Zheng, Xi Zhang, Chunfu Li et al. · Cancer Communications · 2020 · 26 citations · Full text

The 2-Norbornyl Cation via the Fragmentations of <i>exo</i>- and <i>endo</i>-2-Norbornyloxychlorocarbenes:  Distinction without Much Difference

Robert A. Moss, Fengmei Zheng, Ronald R. Sauers et al. · Journal of the American Chemical Society · 2001 · 25 citations

Engineering, Much Difference, Synthetic Photochemistry +18

Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial

Hai‐Xia Fu, Xueyan Sun, Ren Lin et al. · BMC Medicine · 2024 · 22 citations · Full text